Repro India Q1 FY27 preview: revenue ₹121-140 cr range

Why Repro India’s Q1 FY27 print is in focus

Repro India’s Q1 FY27 results are coming into focus as investors position ahead of the July-August 2026 results season. In the preview note provided, the stock is referenced at a CMP of ₹369, alongside a market capitalisation of about ₹531 crore and a price-to-earnings multiple described as “not meaningful.” The setup matters because the company has reported volatile profitability in recent quarters, which can shift perception around the sustainability of the recent revenue momentum. The note frames this as a “trailing-growth” projection rather than a formal analyst estimate. That distinction is important for readers who rely on company guidance and reported financials for decision-making.

Q1 FY27 estimates: revenue range and PAT view

The preview includes a Q1 FY27 estimate range of ₹121-140 crore in revenue. It also carries a profit after tax (PAT) estimate of a loss of ₹1-2 crore for the quarter. The same table uses Q1 FY26 as the base period, showing ₹118 crore in revenue and a net loss of ₹3 crore. The indicated results window is July-August 2026.

How the trailing-growth framework is described

The preview says it is built on a trailing-growth framework applied to the company’s Q1 FY26 base of ₹118 crore revenue and ₹-3 crore net profit. It adds that the “most recent year-on-year growth signal” from Q4 FY26 is used to project Q1 FY27. The note explicitly calls this a Uniresearch trailing-growth projection and not a formal analyst estimate. It also says it should be read alongside the company’s own guidance once released. This means the numbers are presented as a directional model output rather than a company-issued outlook.

What Q4 FY26 disclosures said about momentum

Separate from the preview table, the provided material includes a Q4 FY26 performance snapshot from an investor presentation. Consolidated Q4 FY26 revenue is shown at about ₹141 crore, up 11% year-on-year, and described as the highest quarterly revenue reported in the company’s history. Q4 EBITDA is shown at about ₹13 crore versus about ₹11.6 crore quarter-on-quarter, with an EBITDA margin of 10%. The note also mentions a provision of a non-cash expense of ₹11 crore for MAT credit in the quarter based on new Income Tax Act requirements.

The same disclosure adds a specific expectation: for Q1 FY27, the company expects to deliver the same revenue as that quarter, which it says would represent about 20% year-on-year growth. Investors tracking Q1 FY27 will likely compare this “same as Q4” revenue comment with the preview’s ₹121-140 crore revenue range.

Price references, targets, and the short-term range mentioned

The preview cites a 12-month target range of ₹392-440 (Uniresearch estimate), tied to the same trailing revenue growth trend and current valuation multiple. It also states that over a 3-6 month horizon, the framework points to a range of ₹369-398, contingent on the Q1 FY27 print matching or beating the trailing growth trend. In addition to the CMP of ₹369 cited in the preview, the supplied snippets also include other price references such as “Current Share Price ₹363.95” and a separate “Repro India share price is ₹380.55” (timestamped to 27 May, 4:00 PM), plus a nearby reference to ₹381.5. These differing price points appear to come from different snapshots, and they underline why readers should anchor on a specific date and source when comparing targets.

Company snapshot: business, listings, and valuation markers

Repro India Limited is described as providing printing solutions in India and internationally. Its service list spans value engineering, creative designing, pre-press, printing, post-press, knitting and assembly, warehousing, dispatch, database management, sourcing and procurement, localization, and web-based services. The stock is listed as NSE: REPRO and BSE: 532687, with the sector stated as Printing and Publishing.

Valuation markers in the provided content include a price-to-book (P/B) of 1.56 and a P/E described as “not meaningful” in the preview context. The market cap is shown in two forms: about ₹531 crore in the preview and ₹5.22 billion (about ₹522 crore) in a separate snapshot, which are broadly consistent as rounded figures.

Financial datapoints shown across periods

The provided data includes a quarterly “Net Sales” series (₹ crore): Dec 2024 at 72.84, Mar 2025 at 67.30, Jun 2025 at 56.59, Sep 2025 at 47.23, and Dec 2025 at 59.57. It also includes corresponding operating profit figures for those periods (₹ crore): 9.88, 6.49, 5.22, 5.71, and 8.90.

Another snapshot shows a fiscal period comparison with Total Revenue of 116.47 (Jun 25) versus 123.06 (Mar 25), with net income at -2.73 (Jun 25) versus 1.07 (Mar 25). Separately, a paragraph states: revenue stands at ₹123.06 crore with a quarter-on-quarter decrease from ₹125.94 crore, and a year-on-year decline of 3.22%. The same paragraph states operating profit of ₹6.16 crore, PBDT of ₹9.00 crore, profit before tax of ₹1.60 crore, and net profit of ₹1.13 crore, along with QoQ and YoY percentage changes as provided.

Ownership, filings, and scheduled disclosures

Promoter holding is shown at 46.71% as of Mar 2026, marginally down from 46.78% earlier in FY26 snapshots. The content also lists multiple company events such as “Integrated Financial Fillings” and “Analyst Presentation” dated May 29, 2026, along with earlier analyst presentations and quarterly results dates (for example, Q1 FY26 financial results dated Jul 22, 2025). A “Jul 2026 Announcement” is referenced with a PDF dated 31 Jul 2026, which aligns with the broad July-August 2026 results window mentioned in the estimates table.

Market impact: what investors are likely to track

For the market, the key sensitivity is whether Q1 FY27 revenue lands closer to the preview range of ₹121-140 crore or closer to the company’s stated expectation of “same revenue as this quarter” after Q4 FY26 at about ₹141 crore. On profitability, the preview’s PAT loss estimate of ₹1-2 crore sits between the Q1 FY26 loss of ₹3 crore and the more mixed net income snapshots shown elsewhere, so the direction of bottom-line movement remains central. The Q4 FY26 EBITDA margin of 10% and the mention of a non-cash MAT credit provision of ₹11 crore provide additional context on why reported profit can diverge from operating performance. Valuation references like “P/E not meaningful” also indicate that earnings-based comparisons may remain difficult if profits stay volatile.

Analysis: why the Q1 FY27 number could reshape expectations

The preview’s framework is explicitly tied to trailing signals from Q4 FY26, which was described as a record revenue quarter at about ₹141 crore. If Q1 FY27 revenue trends closer to that level, it would support the idea that the revenue step-up is holding into the new financial year. If revenue prints closer to the lower end of ₹121-140 crore, investors may focus on the gap versus the “same as Q4” expectation stated in the presentation material. On the cost side, the earlier period table showing Total Operating Expense at 117.97 (Jun 25) against Total Revenue of 116.47 highlights how small swings in demand and pricing can push operating income negative. That operating leverage makes margins and cash-related disclosures just as important as the headline revenue figure.

Conclusion

Repro India heads into the July-August 2026 results window with a trailing-growth revenue view of ₹121-140 crore for Q1 FY27 and a PAT loss estimate of ₹1-2 crore. The stock is referenced near ₹369 in the preview, alongside a 12-month target range of ₹392-440 and a shorter 3-6 month framework range of ₹369-398. Investors are likely to weigh the Q1 print against Q4 FY26’s about ₹141 crore revenue record and the company’s stated expectation of delivering similar revenue in Q1 FY27. The next concrete marker in the provided schedule is the late-July 2026 disclosure reference, which should help narrow the range of outcomes once the company reports.